Lifecore Biomedical | SC 13D/A:超过5%持股股东披露文件(修正)-22NW Fund, LP(12.44%),22NW, LP(12.44%)等
Lifecore Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-Dimensional Fund Advisors LP(0.0%)
Lifecore Biomedical | 4:持股变动声明-董事 Schechter Joshua
Lifecore Biomedical | 4:持股变动声明-董事 Calloway Nathaniel
Lifecore Biomedical | 4:持股变动声明-董事 OBUS NELSON
Lifecore Biomedical | 4:持股变动声明-董事 EDWARDS JEFFREY L
Lifecore Biomedical | 4:持股变动声明-董事 Diradoorian Raymond H
Lifecore Biomedical | 4:持股变动声明-董事 HOUDE LOVAS KATRINA
Lifecore Biomedical | 4:持股变动声明-董事 Barbarosh Craig A.
Lifecore Biomedical | 4:持股变动声明-高管 Morberg John D
Lifecore Biomedical | 4:持股变动声明-董事 Calloway Nathaniel
Lifecore Biomedical | SC 13D/A:超过5%持股股东披露文件(修正)-Legion Partners, LLC(15.1%),Legion Partners Asset Management, LLC(15.1%)等
Lifecore Biomedical | SC 13D/A:超过5%持股股东披露文件(修正)-Cove Street Capital, LLC(5.15%),Jeffrey Bronchick(5.15%)等
Lifecore Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(1.8%)
Lifecore Biomedical | SC 13G:超过5%持股股东披露文件
Lifecore Biomedical | SC 13D/A:超过5%持股股东披露文件(修正)-22NW Fund, LP(9.99%),22NW, LP(9.99%)等
Lifecore Biomedical | 4:持股变动声明-董事 Kiper Christopher S
Lifecore Biomedical | 4:持股变动声明-董事 Barbarosh Craig A.
Lifecore Biomedical | 4:持股变动声明-董事 Diradoorian Raymond H
Lifecore Biomedical | 4:持股变动声明-首席执行官 Hall James G
暂无数据